Why Some Forms Generate Supersaturation
A crystalline drug dissolving in a fixed medium tends toward its equilibrium solubility. An amorphous form or a soluble salt can temporarily produce a dissolved concentration above the equilibrium solubility of the stable crystalline form. This condition is supersaturation: a thermodynamic driving force exists for the dissolved drug to return toward the more stable state, but the concentration does not necessarily fall immediately. The time available before that return depends on processes such as precipitation, absorption, and changes in the medium.
The key distinction is between how much drug is dissolved and what concentration the current solid and solution conditions can support at equilibrium. Supersaturation is calculated by comparing those quantities; a change in the equilibrium reference does not by itself instantaneously change the dissolved concentration.
Amorphous Forms: A Higher, Metastable Concentration Scale
An amorphous solid lacks the long-range crystal lattice of a crystalline solid. Its higher free energy commonly gives it a greater apparent or metastable solubility. If dissolution is fast enough, the dissolved concentration can rise above the stable crystal’s equilibrium solubility. The amorphous solubility is not a guarantee that a solution will remain at that concentration: it is a useful upper reference for dissolution under specified conditions, while supersaturation relative to the crystal describes the thermodynamic drive toward the stable state.
A simple well-mixed model can represent dissolution toward an amorphous-form concentration scale while also allowing first-order removal, for example by absorption. Let \(k_d\) be an effective dissolution rate constant, \(k_a\) a first-order removal rate constant, and \(S_{\mathrm{am}}\) the effective concentration scale driving dissolution. While solid remains available, assume constant volume and medium conditions, and write
This is a deliberately compact model, not a universal dissolution law. Its rates summarize more detailed effects such as surface area and interfacial mass transfer. It assumes that \(S_{\mathrm{am}}\), \(k_d\), and \(k_a\) are constant over the interval and that enough solid remains to sustain the modeled dissolution term. If the dose is depleted, the equation must change.
The solution follows by collecting the terms in \(C\): \(dC/dt=k_dS_{\mathrm{am}}-(k_d+k_a)C\). Define \(C_{\infty}=k_dS_{\mathrm{am}}/(k_d+k_a)\), the model’s steady concentration while the assumptions hold. Multiplying by the integrating factor \(e^{(k_d+k_a)t}\) and integrating from 0 to \(t\) gives
Thus the concentration approaches a balance between supply from dissolution and removal. It does not generally approach \(S_{\mathrm{am}}\), because removal continues while dissolution occurs.
Worked Example: Amorphous Dissolution Followed by a Crystal-Form Transition
Consider a hypothetical, well-mixed intestinal compartment with \(C(0)=0\) mg/L, \(S_{\mathrm{am}}=120\) mg/L, \(k_d=0.50\) h\(^{-1}\), and \(k_a=0.20\) h\(^{-1}\). Assume constant conditions and adequate undissolved dose through 2 h. The stable crystalline solubility is \(S_{\mathrm{eq}}=20\) mg/L.
First calculate the model’s steady concentration:
Therefore, \(C(t)=85.71(1-e^{-0.70t})\) mg/L when \(t\) is in hours. At 2 h,
The solution is supersaturated relative to the stable crystal at 2 h. Now suppose the remaining solid converts to the crystalline form at 2 h. The dissolved concentration is continuous at the transition: the form change alone does not remove drug from solution. If precipitation is excluded from this calculation and absorption continues at \(k_a=0.20\) h\(^{-1}\), then while \(C\) remains above 20 mg/L, \(C(t)=64.58e^{-0.20(t-2)}\) mg/L. One hour after the transition, \(C=64.58e^{-0.20}=52.87\) mg/L and \(SR=52.87/20=2.644\). The calculation shows a falling concentration due to removal, not an instantaneous collapse at the transition. It does not predict precipitation.
Salt Forms and pH-Dependent Solubility
A salt can dissolve rapidly and generate a high concentration, but the drug’s ionization state and equilibrium solubility depend on the pH of the surrounding solution. A salt form is not necessarily a permanent increase in the drug’s equilibrium solubility after dilution or a pH change. For a monoprotic weak base, assuming ideal solution behavior and that the neutral form has intrinsic solubility \(S_0\), total equilibrium solubility is approximated by \(S_0[1+10^{(pK_a-pH)}]\). For a monoprotic weak acid, the corresponding expression is \(S_0[1+10^{(pH-pK_a)}]\). These expressions assume that ionization equilibrates rapidly and that activity effects, common-ion effects, and other solubilizing components can be neglected.
A salt can therefore create a transient concentration that exceeds the equilibrium solubility at a later pH. A pH shift can change the solubility reference quickly, while total dissolved drug remains continuous if there is no instantaneous removal. Ionized and neutral species redistribute rapidly; that speciation change is not the same as a change in total dissolved mass.
Worked Example: Salt Dissolution of a Weak Base
Suppose a hypothetical weak base has \(pK_a=6.5\) and intrinsic solubility \(S_0=2.0\) mg/L. At pH 5.5, assume salt dissolution can be represented by \(dC/dt=k_d(S_{\mathrm{eq}}-C)-k_aC\), with \(k_d=0.80\) h\(^{-1}\), \(k_a=0.10\) h\(^{-1}\), and \(C(0)=0\). Take the dose to be sufficient through 2 h.
The ideal weak-base expression gives the equilibrium solubility at pH 5.5:
The concentration approaches \(C_{\infty}=k_dS_{\mathrm{eq}}/(k_d+k_a)\), so \(C_{\infty}=(0.80)(22.0)/(0.90)=19.56\) mg/L. The full trajectory is \(C(t)=19.56(1-e^{-0.90t})\) mg/L. At 2 h, \(C(2)=19.56(1-e^{-1.80})=16.32\) mg/L. Relative to the pH 5.5 equilibrium solubility, \(SR=16.32/22.0=0.7418\); the concentration is not yet supersaturated at that pH.
If pH then changes to 7.5, the ideal equilibrium solubility becomes \(2.0[1+10^{(6.5-7.5)}]=2.20\) mg/L. Immediately after the pH shift, \(C\) remains 16.32 mg/L in the absence of an instantaneous mass-removal process, so \(SR=16.32/2.20=7.418\). The pH shift creates supersaturation relative to the new equilibrium reference. This calculation identifies the driving force; it does not specify when or how much precipitation occurs.
Worked Example: Total and Neutral Concentration Across a pH Shift
Use the same hypothetical weak base, with \(pK_a=6.5\). Suppose the total dissolved concentration immediately before a rapid pH change from 5.5 to 7.5 is 15.0 mg/L. Assume acid-base speciation equilibrates rapidly, there is no instantaneous precipitation, and subsequent removal is first-order with \(k_a=0.10\) h\(^{-1}\).
For a weak base, the neutral fraction is \(1/[1+10^{(pK_a-pH)}]\). At pH 5.5 it is \(1/(1+10)=0.09091\), so the neutral concentration is \((15.0)(0.09091)=1.364\) mg/L. Immediately after the pH shifts to 7.5, the neutral fraction is \(1/(1+0.1)=0.9091\), and the neutral concentration is \((15.0)(0.9091)=13.64\) mg/L. Total dissolved concentration is still 15.0 mg/L; the neutral concentration changes because the species redistribute.
If no solid dissolution or precipitation occurs during the next hour and only the specified first-order removal acts, the total concentration is \(C(t)=15.0e^{-0.10t}\) mg/L, with \(t\) measured from the pH shift. At 1 h, \(C=15.0e^{-0.10}=13.57\) mg/L. At pH 7.5 the ideal equilibrium solubility is 2.20 mg/L, giving \(SR=13.57/2.20=6.168\). This remains a supersaturated solution in the calculation; the result does not claim that it will persist indefinitely.
Interpreting Transitions and Diagnosing a Model
A pH or solid-form transition changes the conditions defining equilibrium. In a model without an instantaneous mass-transfer event, concentration is continuous at the transition, but \(S_{\mathrm{eq}}\) can change abruptly. Consequently, \(SR\) can jump even though \(C\) does not. This distinction is essential when interpreting concentration-time data: a sudden change in calculated supersaturation may come from the denominator, not from a sudden concentration change.
Check a proposed trajectory against the assumptions and mass balance. For a finite dose \(D\) in volume \(V\), the dissolved concentration cannot exceed \(D/V\), and cumulative removal must also be included when checking how much dose remains. A predicted trajectory exceeding that dose limit signals that the assumed dissolution supply cannot continue. Also check whether pH, volume, and rate constants can reasonably be treated as constant over the interval. If the pH changes gradually or the medium is strongly buffered, a step change in pH may be a poor approximation.
The simple models here should be distinguished from other common approaches. A crystalline equilibrium model predicts a concentration constrained by stable-form solubility under the specified conditions; it cannot by itself represent a transient concentration above that value. A sink-dissolution approximation treats the bulk concentration as small relative to solubility, simplifying the dissolution driving force, but can misrepresent a non-sink or supersaturated profile. A kinetic dissolution model such as the first-order form used above represents a time course, but its effective rate constant may combine several physical effects. More detailed particle-based dissolution models can represent changing area and size distributions, at the cost of additional parameters and data requirements.
The present calculations deliberately stop short of predicting precipitation. They establish concentration and supersaturation trajectories under stated dissolution and removal assumptions. Supersaturation alone does not determine a precipitation time or rate; those require additional kinetic information. Other limitations include ideal pH-solubility expressions, neglected activity effects, and the assumption that a measured concentration represents freely dissolved drug rather than drug associated with other solution components.
Common Mistakes
- Wrong: “The solid changes to the crystal form, so the dissolved concentration instantly becomes the crystalline solubility.” Correction: The equilibrium reference changes; concentration remains continuous unless an actual mass-transfer process changes it.
- Wrong: “A salt always raises the drug’s equilibrium solubility.” Correction: Salt dissolution may generate a transient high concentration, while pH and solution conditions determine the relevant equilibrium solubility.
- Wrong: “If \(SR>1\), precipitation must occur immediately.” Correction: \(SR>1\) indicates a thermodynamic driving force, not a specified precipitation time or rate.
- Wrong: “The concentration approaches \(S_{\mathrm{am}}\) even while absorption removes drug.” Correction: With simultaneous dissolution and first-order removal, the steady concentration is \(k_dS_{\mathrm{am}}/(k_d+k_a)\), provided the model assumptions and solid supply remain valid.
Check Your Understanding
Answer each question using the assumptions stated. Brief solutions follow the questions.
- A weak base has \(S_0=1.5\) mg/L and \(pK_a=7.0\). What is its ideal total equilibrium solubility at pH 6.0?
- If \(C=12\) mg/L just before a pH shift and the new \(S_{\mathrm{eq}}\) is 3 mg/L, what is the immediate \(SR\) if concentration is continuous?
- In the first-order dissolution-and-removal model, what happens to \(C_{\infty}\) when \(k_a\) increases while \(k_d\) and \(S_{\mathrm{am}}\) stay fixed?
- Why can a pH shift change \(SR\) without changing total dissolved concentration at the instant of the shift?
Solutions. (1) \(1.5[1+10^{(7.0-6.0)}]=1.5(11)=16.5\) mg/L. (2) \(SR=12/3=4\), so the solution is supersaturated relative to the new reference. (3) Since \(C_{\infty}=k_dS_{\mathrm{am}}/(k_d+k_a)\), increasing \(k_a\) increases the denominator and lowers \(C_{\infty}\). (4) The pH shift changes the pH-dependent equilibrium solubility, while rapid speciation redistribution does not itself change total dissolved drug; absent instantaneous mass transfer, \(C\) is continuous.